Webinar Announcement: Metabolomics as a Tool for Predictive Toxicology

Drug Safety Executive Council™ to host industry panel discussion on the role of metabolomics in adverse event prediction

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Needham, MA (PRWEB) April 23, 2012

The Drug Safety Executive Council™ (DSEC™) is hosting a webinar entitled "Metabolomics as a Tool for Predictive Toxicology." The 60-minute webinar, scheduled for today, Monday, April 23, 2012 at 11:00 a.m. ET and is free for current DSEC members. If you are not a DSEC member, sign up for the community so that you may access this live broadcast. Additional information and registration details are available at http://www.drugsafetycouncil.org.

The webinar will be moderated by DSEC’s Scientific Director, Ernie Bush, PhD and will feature a panel of industry experts discussing how metabolomics can improve the compound selection process, specifically, current best practices of using metabolomics tools in safety assessment.

About DSEC
The Drug Safety Executive Council™ (DSEC™) is an online community focused on the development of better and safer medicines. DSEC is a platform for biopharmaceutical companies, contract research organizations and academics to share knowledge and exchange ideas on improving the drug pipeline. Visit http://www.drugsafetycouncil.org.

DSEC™ is managed by Cambridge Healthtech Associates™ (CHA™), a firm that uses its collaborative model to improve the speed and economics of life science R&D, leveraging its consulting, technology evaluations and communities. Visit http://www.chacorporate.com.


Contact